Abstract

Breast cancer treatment is undergoing rapid evolution, driven by advancements in targeted therapies, immunotherapy, and precision medicine. Amidst these changes, the role of surgery in breast cancer management is being reevaluated. This article explores the current landscape of breast cancer treatment, highlighting the potential impact of emerging therapies on the future role of surgery. While surgery remains a cornerstone of treatment, its role may evolve to incorporate de-escalation strategies, integration with novel therapies, and a heightened focus on quality of life. By embracing these shifts, clinicians can optimize treatment outcomes and enhance the holistic care of breast cancer patients.